Table 2 Individual and mean fluke counts and clinical efficacy (%) against triclabendazole (TCBZ)-resistant Fasciola hepatica obtained after the administration of TCBZ alone (10 mg/kg, i.r.) or co-administered with ivermectin (IVM, 0.2 mg/kg, s.c.) and methimazole (MTZ, 1.5 mg/kg, i.m.) to Fasciola hepatica-infected sheep.

From: Unchanged triclabendazole kinetics after co-administration with ivermectin and methimazole: failure of its therapeutic activity against triclabendazole-resistant liver flukes